Table 3. Number and percentage of subjects with anti HbsAg ≥10 IU/mL in adults (group II).
| Description | 0118S (n=65) | 0218S (n=66) | 0318S (n=63) | Control (n=65) | p-valuea) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | |||
| Anti-HbsAg ≥10 mIU/mL | 0.502 (pre) | |||||||||
| 1.000 (post) | ||||||||||
| No. (%SP) | 16 (24.61) | 65 (100.00) | 19 (28.79) | 66 (100.00) | 26 (41.27) | 63 (100.00) | 24 (36.92) | 64 (98.46) | ||
| (95% CI) | (0.148–0.369) | (0.945–1.000) | (0.145–0.364) | (0.946–1.000) | (0.276–0528) | (0.943–1.000) | (0.226–0.466) | (0.917–1.000) | ||
Values are presented as number of available observations (%), unless otherwise stated.
HBsAg, hepatitis B surface antigen; %SP, seroprotection rate; CI, confidence interval.
a)p-value based on chi-square test/Fisher exact.